Cambia Health Solutions (Formerly Known as the Regence Group)

Not-for-profit health insurer covering four states in the Northwest, US

Based in OR

🤖

AI Overview

With $2.2M in lobbying spend across 28 quarterly filings, Cambia Health Solutions (Formerly Known as the Regence Group) is a significant lobbying presence.

$2.2M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$240K
2019$155K
2020$320K
2021$320K
2022$320K
2023$320K
2024$160K
2025$320K

Lobbying Firms

RED+BLUE STRATEGIES

What They Lobby For

  • Departments of Health and Human Services and Labor's rules regarding Associated Health Plans. Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces. H.R.1625/PL-No.115 - Consolidated Appropriations Act of 2018 - Policy related to individual market stabilization. H.R. 1301 - Continuing Resolution of 2018/PL 115-124- advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax. S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market. Issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.
  • Departments of Health and Human Services and Labor's rules regarding Associated Health Plans. Administrative regulations, rules and guidances related to insurance market stability for both state and federal individual insurance marketplaces. H.R.1625/PL-No.115 - Consolidated Appropriations Act of 2018 - Policy related to individual market stabilization. H.R. 1301 - Continuing Resolution of 2018/PL 115-124- advocacy for the inclusion of the CHRONIC Act as well as repeal and/or delay of the Health Insurance Tax. S. 1028/ H.R. 3759- RAISE Family Care Givers Act - issues related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.
  • Department of Health and Human Services and Labor's rules regarding Associated Health Plans. Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces. P.L. 115-119- RAISE Family Care Givers Act - work on implementation of the law related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market. Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.
  • Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.
  • Administrative regulations, rules and guidelines related to insurance market stability for both state and federal individual insurance marketplaces. P.L. 115-119- RAISE Family Care Givers Act - work on implementation of the law related to developing better systems to integrate families into palliative and end-of-life care and related programs dedicated to the work. S. 1334/H.R. 2797- Patient Choice and Quality Care Act of 2017 - Issues related to better integrating and improving palliative and end of life care into our nation's health care system. Rules and Regulations regarding 1332 waivers and other issues impact the private insurance market. Trump Administration Blueprint to lower prescription drug prices - issues related to containing and decreasing prescription drug costs to consumers. Issues related to making health care in the United States of America more transparent and consumer-focused.
  • Trump Administration regulations regarding prescription medications in the Medicare and Medicaid programs. Issues related to improving palliative and end of life care through the Medicare program.
  • S. 1895 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications. S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax. Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs). Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare. Trump Administration regulations regarding the cost of prescription medication in the Medicare and Medicaid programs Trump Administration guidance and regulations regarding insurance marketplaces. Issues related to improving palliative and end of life care in the United States.
  • H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax. S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications. S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax. Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs). Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare. Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs Trump Administration guidance and regulations regarding insurance marketplaces. Issues related to improving palliative and end of life care in the United States.
  • Trump Administration regulations regarding HHS risk adjustment data validation the Medicare programs. H.R. 647/ S. 2080 - Issues related to improving palliative and end of life care through the Medicare program.
  • H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act - Issues related to the role of health plans in the COVID-19 response. H.R. 6201 - Families First Coronavirus Response Act - Issues related to insuring the safety of American families, workers and health providers and the role healthplans can play. H.R. 748 - The CARES Act - Issues related to funding for providers providing care for people with COVID-19. H.R. 1865 - Consolidated Appropriations for FY 2020 - Issues related to the delay or repeal of the HIT tax. S. 1895/H.R. 3630 - Lower Health Costs Act of 2019 - Issues related to transparency and lowering the cost of prescription medications. S.80, S. 172, HR 1398/S.172 - Support for full repeal and two year delay of the Health Insurance Tax. Issues related to shoring up coverage in the individual marketplaces in certain state based exchanges (SBEs). Issues related to using HIT to allow better consumer transparency to quality and cost in healthcare. Trump Administration regulations regarding HHS Risk Adjustment Data Validation in the Medicare programs Trump Administration guidance and regulations regarding insurance marketplaces. Issues related to improving palliative and end of life care in the United States.

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.